“The commitment fee allocated to the future milestone funding of $2.2 million was fully expensed under Other Expenses, because it is unlikely that the Company will achieve any of the three milestones by September 30, 2018.”
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links